Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.

Fluconazole (UK 49,858), a new orally administered bis-triazole, was compared with ketoconazole for activity in synthetic broth dilution susceptibility tests against Candida albicans and also in treatment of experimental systemic candidal infections in rats. In vitro studies indicated that fluconazo...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Rogers, T E, Galgiani, J N
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1986
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180572/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3022641/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.3.418
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!